Trial intelligence / Profile preview

Botulinum toxin A volume–response for equinus gait in children with cerebral palsy

2014-004474-42Phase 4Terminated

Sponsor
Copenhagen University Hospital - Amager and Hvidovre
Start
Mar 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of botulinum toxin type A in cerebral palsy (CP) and equinus contracture (3 arms), sponsored by Copenhagen University Hospital - Amager and Hvidovre. Started Mar 2015; status: terminated.

02

Drugs

botulinum toxin type A
03

Conditions

cerebral palsy (CP)equinus contracture

Beyond the preview

Go deeper on 2014-004474-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004474-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call